{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif
Survey Questionnaire
  1. How many years have you been practicing? *

  2. Are you specialized in managing dry eye disease? *

  3. What type of practice do you have? *

  4. Which age group is most commonly diagnosed with Dry Eye Disease (DED) in your practice? *

  5. Approximately what percentage of dry eye patients do you see in the following age groups *
    6. @foreach(['Less than 18 years', '18-25 years', '26-40 years', '41-60 years', 'More than 60 years'] as $index => $label) @endforeach
    {{ $label }}
    %
    Total
  6. Based on the duration of diagnosis, please provide an approximate breakdown of patients with Dry Eye Disease *
    7. @foreach(['Less than 15 days', '16 days to less than 1 month', 'More than 1 month to 3 months', 'More than 3 months'] as $index => $label) @endforeach
    {{ $label }}
    %
    Total
  7. What are the most common causes of Dry Eye Disease (DED) in your practice? (Tick all applicable) *

  8. In your clinical practice, could you provide an approximate breakdown of patients with Dry Eye Disease based on the type of dry eye disease? *
    9. @foreach(['Aqueous tear deficiency','Blepharitis/Meibomian gland dysfunction','Goblet cell deficiency/Mucin deficiency','Exposure-related dysfunctional tear syndrome'] as $index => $label) @endforeach
    {{ $label }}
    %
    Total
  9. What percentage of dry eye disease patients have co-morbidities, based on your observations in practice? *

  10. Kindly rank the most common co-morbidities observed in Dry Eye Disease patients in your practice (from most common to least common): *
    11. Glaucoma
    Post-operative
    Rheumatoid arthritis
    Diabetes

  11. Based on your clinical practice, which symptoms are most common in patients diagnosed with Dry Eye Disease (DED)? (Please tick the applicable option) *

  12. Which tests do you most often use to evaluate dry eye disease? (Tick all applicable) *

  13. Which additional tests do you usually order for patients with severe or refractory DED? *

  14. How often do you screen for systemic conditions associated with DED (e.g., Sjögren's syndrome, rheumatoid arthritis)? *

  15. Approximately what percentage of patients with dry eye disease require artificial tear formulations in your practice? *

  16. What factors influence your choice of tear substitutes? *

  17. Do you have a preferred artificial tear? *

  18. Rank your preferred tear substitutes/ocular lubricants for patients diagnosed with dry eye disease *
    19. @php $options = [ "Cellulose-based", "Mineral oil-based", "Hyaluronate-based", "Polyethylene glycol-based", "Any other", ]; $inputIds = ["q18_1", "q18_2", "q18_3", "q18_4", "q18_5"]; @endphp @for ($i = 0; $i < count($options); $i++) @endfor
    {{ $options[$i] }} @if($options[$i]=='Any other') @endif
  19. As per your practice, what percentage of the following patients might have complaints of dry eye disease? (Please mention in % for each condition) *
    20. @foreach(['Post-LASIK','Post-Cataract','Post-Photorefractive Keratectomy'] as $index => $label) @endforeach
    {{ $label }}
    %
    Total
  20. What is the preferred treatment option for the following patients with complaints of dry eye disease? (Please mention as applicable for each condition) *
    21. @foreach(['Post-LASIK','Post-Cataract','Post-Photorefractive Keratectomy'] as $index => $label) @endforeach
    {{ $label }}
  21. What is the main test you use to monitor the treatment effect? *

  22. In which type of dry eye patients is topical cyclosporine most commonly recommended? *

  23. When would you consider discontinuing or reducing the frequency of topical cyclosporine in a patient with DED? *

  24. What counselling points do you provide to patients regarding the administration of topical cyclosporine? *

  25. When initiating topical cyclosporine therapy for DED, what is the typical recommended dosing frequency? *

  26. How do you monitor treatment with topical cyclosporine therapy in patients with DED? *

  27. How do you address non-compliance with prescribed DED treatments? *

  28. In cases of persistent DED, what factors influence your decision to escalate treatment? *

  29. When do you consider referral to a cornea specialist in the management of DED? *